Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful
Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.
Glenmark Therapeutics | 10/03/2025 | By Aishwarya | 171
Glenmark Therapeutics Unveils Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 percent (OTC) as compared to the active ingredient in Pataday Twice Daily Relief.
Glenmark Therapeutics | 20/08/2024 | By Aishwarya | 160
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy